The effect of MELatOnin on Depression, anxietY, cognitive function and sleep disturbances in patients with breast cancer. The MELODY trial: protocol for a randomised, placebo-controlled, double-blinded trial

INTRODUCTION: Breast cancer represents about one-third of all cancer diagnoses and accounts for about 15% of cancer deaths in women. Many of these patients experience depression, anxiety, sleep disturbances and cognitive dysfunction. This may adversely affect quality of life and also contribute to m...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Hansen, Melissa Voigt, Madsen, Michael Tvilling, Hageman, Ida, Rasmussen, Lars Simon, Bokmand, Susanne, Rosenberg, Jacob, Gögenur, Ismail
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Group 2012
Soggetti:
Surgery
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3278491/
https://ncbi.nlm.nih.gov/pubmed/22240653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2011-000647
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi